Grifois, S.A.

GRFS XNAS

Market Cap

5.2B

Short interest (May 15)

0.9%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.67%

↑ 78.0%

Available Shares

9M

↑ 1.8%

Price Chart

Company Overview

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Company Info

Exchange: NASDAQ
CIK: 0001438569
Asset Type: ADRC

Market Data

Market Cap: $5,192,789,630
Employees: 25,247
Status: Active

Short Interest

Current Borrow Fee 0.67%
Range: 0.48% - 0.67%
Available Shares 9M
Range: 8.2M - 8.6M

Recent Changes

Fee Change: ↓ 10.4%
Available Change: ↓ 1.7%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime